(Press-News.org) A ground-breaking discovery by Monash University researchers could revolutionise treatments given to lupus sufferers, saving thousands of people each year from serious illness or death caused by secondary infections.
Lupus is a vicious and widespread autoimmune disease that can attack any part of the body. It affects one in 1,000 Australians and 5 million people worldwide, and its victims are typically young women. Indigenous and Asian people suffer higher rates than other groups.
Current treatments for lupus essentially 'switch off' the patient's immune system to stop it attacking their body, according to lead researcher Dr Will Figgett, from Monash University's Department of Immunology.
This leaves patients vulnerable to any passing infection, and given that they are often in hospital due to the severity of lupus, the risk of exposure to another disease is high.
Dr Figgett and colleagues, working with world leader in immunology, Professor Fabienne Mackay, from the Department of Immunology - have found a way to stop lupus without stopping the immune system by focussing on a specific receptor found on B cells - the 'soldiers' of the immune system.
In healthy people, B cells attack diseases by producing antibodies that destroy invading pathogens. In lupus sufferers, B cells are misdirected to produce autoantibodies - cells that destroy the patient's own healthy tissue. Most commonly, lupus affects the skin and joints, but it can also strike the brain, kidneys and almost anywhere in the body.
In order to survive, B cells rely on a particular protein - called B cell Activating Factor of the TNF Family (BAFF), however too much BAFF causes lupus to develop. Each B cell carries three different kinds of receptor that detect BAFF in the blood stream. The receptors are known as BAFF-R, BCMA, and TACI. It is the TACI receptor that responds to excesses of BAFF, becoming overstimulated and triggering production of even stronger autoantibodies to attack healthy tissue.
Researchers found that if the TACI receptor is deleted, the B cells remain intact but lupus doesn't develop no matter how much BAFF is in the blood.
Dr Figgett said that while B cells are vital to a healthy immune system, the TACI receptor itself is not crucial - the cell can fight most diseases without it.
"Among current lupus drugs, the most recent advancement is belimumab, which was thought to work by 'mopping up' the large amounts of extra BAFF in the patients and limiting the production of new B cells while under treatment," he said.
"This does help, but patients are left defenceless against a host of other illnesses. We have discovered that where the TACI receptor had been deleted from the genome, high BAFF levels don't get lupus even though they should.
The first step to make a new medicine is to find a suitable target. This is a better way to try and cure lupus because most of the natural immune system will remain intact to protect the patient," Dr Figgett said.
INFORMATION:
This news release is available in Spanish.
Compelling clinical activity of PM1183 in second line, achieving 67% response rate and a progression-free survival of 4.7 months in patients with small cell lung cancer (SCLC), a type of tumor with very limited treatment alternatives
Data from an interim analysis from the pivotal Phase 3 trial of YONDELIS® in soft tissue sarcoma, SAR-3007, will be presented in an oral presentation
Phase 2 data showcase activity of YONDELIS® in malignant pleural mesothelioma, a rare form of lung cancer that is largely related ...
Even a busy job may not provide enough exercise to meet current activity recommendations for the prevention of cardiovascular disease, according to a study reported today at the EuroPRevent congress in Lisbon.1
Dr Eleanor McIntyre from the Galway University Hospital in Ireland said that the workplace - where most adults spend around 60% of their waking hours - "represents a significant domain where short bouts of physical activity can be accrued and counted towards the recommended guidelines" for CVD prevention. However, results from this small study, which assessed the ...
WASHINGTON (May 13, 2015) -- An early phase study testing an anti-PDL1 agent in combination with standard chemotherapy in the treatment of advanced non-small cell lung cancer has provided promising early results, prompting multiple phase III studies in lung cancer. The findings are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO).
In this phase 1b study, patients with untreated non-small cell lung cancer received one of three standard platinum-based chemotherapy regimens (paclitaxel/carboplatin, pemetrexed/carboplatin or nab-paclitaxel/carboplatin) ...
MANHATTAN, Kansas -- Our belief in pure evil influences our feelings about capital punishment, finds a Kansas State University psychology study.
Donald Saucier, associate professor of psychological sciences and 2015-2016 Coffman chair for distinguished teaching scholars, looked at how beliefs in pure evil influenced how people treated those who committed crimes. He recently completed the study with Russell Webster at St. Mary's College of Maryland.
Approximately 200 participants were given a summary of a case in which a murderer confessed to his crime. Researchers then ...
AURORA, Colo. (May 14, 2015) - More than half of all Medicaid enrollees prefer the "one-stop shop" of a hospital emergency department to receive care for conditions that could be treated effectively at a primary care clinic, according to an article by a researcher at the University of Colorado School of Medicine on the Anschutz Medical Campus.
The finding exposes a gap in the services provided to Medicaid enrollees. From a patient's perspective, going to the hospital emergency department may be less expensive because patients can avoid costs of travel and time away from ...
PHILADELPHIA - In the first-of-its-kind study since the passage of the HIV Organ Policy Equity Act (the HOPE Act), which lifted the ban on organ donations from one HIV-positive person to another, Penn Medicine researchers report on the quality of these organs and how their use might impact the country's organ shortage. The study, published online ahead of print May 14 in the American Journal of Transplantation, revealed that there are nearly 400 HIV-positive potential organ donors who could be sources of donated organs annually for HIV-positive patients waiting for organ ...
All land is not created equal. Some ecosystems do triple duty in the benefits they provide to society. Massachusetts forests, for example, filter public drinking water while also providing habitat for threatened species and storing carbon to combat climate change.
Ecologists and conservation groups single out the hardest-working ecosystems -- called "hotspots" -- for their exceptional conservation value. A new study published today in the Journal of Applied Ecology reports that the number of ecosystem hotspots has increased in Massachusetts over the past decade, with ...
In 2013, the United States government passed the HIV Organ Policy Equity (HOPE) Act, which allows research to be conducted on the safety of organ donation from deceased donors with HIV to recipients with HIV. A new study published in the American Journal of Transplantation explores the quality of these organs and how their use might impact the country's organ shortage.
In the United States, there are not enough organ donors to meet the needs of all patients who might benefit from lifesaving organ transplants. Some patients waiting for organs are infected with HIV, and ...
CHICAGO -- With the increasing demand for food with health benefits, high nutritional value food materials are attracting more attention from both consumers and food manufacturers. A new study by researchers at Wilmar (Shanghai) Biotechnology Research and Development Center Co., Ltd. in the Journal of Food Science, published by the Institute of Food Technologists (IFT), found that germinated buckwheat, an important raw material for food and functional food production, had better nutritional value than ungerminated buckwheat.
Germination is a complex process in which ...
An article publishing online today in Brain: A Journal of Neurology has found that individual differences in brain structure could help to determine the risk for future drug addiction. The study found that occasional users who subsequently increased their drug use compared with those who did not, showed brain structural differences when they started using drugs.
In the two studies, researchers, led by Dr. Benjamin Becker, scanned the brain structure of 66 participants to provide the first likely evidence showing volumes of fronto-striato-limbic regions of the brain have ...
